OÜ PharmaOneRegistered
Key figures
3 942 753 €+9,7%
Revenue 2025
+17,6%
Average annual growth 2019–2025
Ratios
20251,1%
Profit margin
3,0%
EBITDA margin
−90,2%
Equity ratio
0,4×
Current ratio
−5,7%
Return on equity
883 €
Average gross salary
Balance sheet structure
Current assetsNon-current assetsLiabilitiesEquity
Quarterly figures
| Quarter | Revenue | Number of employees | Labour taxes |
|---|---|---|---|
| Q2 2026 | 962 150 € | 16 | 18 938 € |
| Q1 2026 | 1 035 146 € | 14 | 17 077 € |
| Q4 2025 | 1 005 283 € | 13 | 17 477 € |
| Q3 2025 | 940 770 € | 13 | 17 364 € |
| Q2 2025 | 992 432 € | 12 | 17 893 € |
| Q1 2025 | 963 178 € | 12 | 17 353 € |
Source: Tax Board open data — based on VAT returns, may not exactly match revenue in the annual report. Updated quarterly.
Dividends
calculated2025
No dividends were distributed.
History
20250 €
20240 €
2023 ~434 913 €
20220 €
20210 €
20200 €
Previous year's retained earnings + previous year's profit − current retained earnings.
Summary of financial statements2019–2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Balance sheet — assets | |||||||
| Total current assets | 351 294 | 477 773 | 510 430 | 583 994 | 572 507 | 551 758 | 596 214 |
| Total non-current assets | 177 571 | 7812 | 1003 | 219 | 378 724 | 302 979 | 227 234 |
| Total assets | 528 865 | 485 585 | 511 433 | 584 213 | 951 231 | 854 737 | 823 448 |
| Balance sheet — liabilities and equity | |||||||
| Current liabilities | 1 096 888 | 1 138 335 | 1 137 080 | 812 980 | 1 733 336 | 1 639 662 | 1 566 035 |
| Non-current liabilities | — | — | — | 100 000 | 0 | 0 | 0 |
| Total liabilities | 1 096 888 | 1 138 335 | 1 137 080 | 912 980 | 1 733 336 | 1 639 662 | 1 566 035 |
| Share capital | 2500 | 2500 | 2500 | 2500 | 2500 | 2500 | 2500 |
| Retained earnings of previous periods | −161 695 | −570 523 | −655 250 | −628 147 | −766 180 | −784 605 | −787 425 |
| Profit for the year | −408 828 | −84 727 | 27 103 | 296 880 | −18 425 | −2820 | 42 338 |
| Total equity | −568 023 | −652 750 | −625 647 | −328 767 | −782 105 | −784 925 | −742 587 |
| Income statement | |||||||
| Sales revenue | 1 490 825 | 1 029 275 | 1 149 051 | 1 258 463 | 1 942 550 | 3 592 709 | 3 942 753 |
| Operating profit | −389 336 | −62 281 | 49 488 | −49 307 | −10 352 | −2823 | 42 335 |
| EBITDA | −368 024 | −40 969 | 50 881 | −48 523 | 2542 | 72 922 | 118 080 |
| Profit before income tax | −408 828 | −84 727 | 27 103 | 296 880 | −18 425 | −2820 | 42 338 |
| Profit for the reporting year | −408 828 | −84 727 | 27 103 | 296 880 | −18 425 | −2820 | 42 338 |
| Labour costs | 402 810 | 235 482 | 29 568 | 90 581 | 109 345 | 151 919 | 165 970 |
| Depreciation of non-current assets | 21 312 | 21 312 | 1393 | 784 | 12 894 | 75 745 | 75 745 |
| Other indicators | |||||||
| Employees | 14 | 12 | 1 | 3 | 3 | 4 | 6 |
| Calculated dividend | — | 0 | 0 | 0 | 434 913 | 0 | 0 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
CompanyPersonShareholderOther roleAdditional link
Annual reportsPDF, XBRL
Loading list of reports…
Source: e-Business Register (RIK). Files open/download directly from the official register.
Related companies
Same activity — Ravimite jaemüük